Sequential measurements of IGF-I serum concentrations in adolescents with Laron syndrome treated with recombinant human IGF-I (rhIGF-I)

Background: Recombinant human insulin-like growth factor 1 (rhIGF-I) has been approved as an orphan drug for the treatment of growth failure in children and adolescents with severe primary IGF-I deficiency (SPIGFD) with little pharmacokinetic data available. Therefore, sequential measurements of ser...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Breil, Thomas (VerfasserIn) , Kneppo, Carolin (VerfasserIn) , Bettendorf, Markus (VerfasserIn) , Müller, Hermann L. (VerfasserIn) , Kapelari, Klaus (VerfasserIn) , Schnabel, Dirk (VerfasserIn) , Woelfle, Joachim (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 11.07.2018
In: The journal of pediatric endocrinology and metabolism
Year: 2018, Jahrgang: 31, Heft: 8, Pages: 895-902
ISSN:2191-0251
DOI:10.1515/jpem-2018-0139
Online-Zugang:Resolving-System, Informationsseite zum Volltext, Volltext: https://doi.org/10.1515/jpem-2018-0139
Volltext
Verfasserangaben:Thomas Breil, Carolin Kneppo, Markus Bettendorf, Hermann L. Müller, Klaus Kapelari, Dirk Schnabel, Joachim Woelfle

MARC

LEADER 00000caa a2200000 c 4500
001 1665915196
003 DE-627
005 20230427160301.0
007 cr uuu---uuuuu
008 190520s2018 xx |||||o 00| ||eng c
024 7 |a 10.1515/jpem-2018-0139  |2 doi 
035 |a (DE-627)1665915196 
035 |a (DE-599)KXP1665915196 
035 |a (OCoLC)1341224775 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Breil, Thomas  |d 1981-  |e VerfasserIn  |0 (DE-588)137146086  |0 (DE-627)59033803X  |0 (DE-576)302372385  |4 aut 
245 1 0 |a Sequential measurements of IGF-I serum concentrations in adolescents with Laron syndrome treated with recombinant human IGF-I (rhIGF-I)  |c Thomas Breil, Carolin Kneppo, Markus Bettendorf, Hermann L. Müller, Klaus Kapelari, Dirk Schnabel, Joachim Woelfle 
264 1 |c 11.07.2018 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 15.08.2019 
520 |a Background: Recombinant human insulin-like growth factor 1 (rhIGF-I) has been approved as an orphan drug for the treatment of growth failure in children and adolescents with severe primary IGF-I deficiency (SPIGFD) with little pharmacokinetic data available. Therefore, sequential measurements of serum IGF-I, glucose, potassium, insulin and cortisol were performed in patients treated with rhIGF-I to evaluate their significance in safety and efficacy. Methods: Repetitive blood samples were taken after meals before and 30, 60, 120, 180 and 360 min after rhIGF-I injections in two male patients with Laron syndrome at times of dose adjustments. Results: Maximal IGF-I concentrations were observed 2 h after injections (495 ng/mL) and concentrations were still higher 6 h after injections than at baseline (303 ng/mL vs. 137 ng/mL). Thirteen percent of all and 33% of maximum IGF-I concentrations were greater than +2 standard deviation score (SDS) calculated for bone age (BA) (IGF-I SDS BA) rather than chronological age (CA) as BA was significantly delayed to CA by 3.2 years (p=0.0007). Height velocities correlated with individual maximum IGF-I SDS BA (ρ=0.735; p<0.0001). Serum insulin, cortisol and glucose did not correlate with IGF-I concentrations, but serum potassium showed a negative correlation (ρ=−0.364; p<0.0001) with IGF-I concentrations. Conclusions: Sequential measurements of serum IGF-I, glucose and potassium in patients with Laron syndrome may aid in optimizing and individualizing rhIGF-I treatment. IGF-I concentrations should be referenced according to BA which better reflects the biological age. The inverse correlation of IGF-I and serum potassium concentrations after injections of rhIGF-I has not been reported before and warrants further consideration. 
700 1 |a Kneppo, Carolin  |d 1973-  |e VerfasserIn  |0 (DE-588)129592935  |0 (DE-627)473365138  |0 (DE-576)297738739  |4 aut 
700 1 |a Bettendorf, Markus  |e VerfasserIn  |0 (DE-588)111028876  |0 (DE-627)589912151  |0 (DE-576)30212246X  |4 aut 
700 1 |a Müller, Hermann L.  |e VerfasserIn  |0 (DE-588)1188420194  |0 (DE-627)1667347977  |4 aut 
700 1 |a Kapelari, Klaus  |e VerfasserIn  |4 aut 
700 1 |a Schnabel, Dirk  |e VerfasserIn  |0 (DE-588)1167356802  |0 (DE-627)1031023747  |0 (DE-576)51111673X  |4 aut 
700 1 |a Woelfle, Joachim  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t The journal of pediatric endocrinology and metabolism  |d Berlin [u.a.] : de Gruyter, 1985  |g 31(2018), 8, Seite 895-902  |h Online-Ressource  |w (DE-627)641391293  |w (DE-600)2583847-7  |w (DE-576)337259631  |x 2191-0251  |7 nnas  |a Sequential measurements of IGF-I serum concentrations in adolescents with Laron syndrome treated with recombinant human IGF-I (rhIGF-I) 
773 1 8 |g volume:31  |g year:2018  |g number:8  |g pages:895-902  |g extent:8  |a Sequential measurements of IGF-I serum concentrations in adolescents with Laron syndrome treated with recombinant human IGF-I (rhIGF-I) 
856 4 0 |u https://doi.org/10.1515/jpem-2018-0139  |x Resolving-System  |y Informationsseite zum Volltext  |3 Volltext 
951 |a AR 
992 |a 20190815 
993 |a Article 
994 |a 2018 
998 |g 111028876  |a Bettendorf, Markus  |m 111028876:Bettendorf, Markus  |d 910000  |d 910500  |e 910000PB111028876  |e 910500PB111028876  |k 0/910000/  |k 1/910000/910500/  |p 3 
998 |g 129592935  |a Kneppo, Carolin  |m 129592935:Kneppo, Carolin  |d 910000  |d 910500  |e 910000PK129592935  |e 910500PK129592935  |k 0/910000/  |k 1/910000/910500/  |p 2 
998 |g 137146086  |a Breil, Thomas  |m 137146086:Breil, Thomas  |d 910000  |d 910500  |e 910000PB137146086  |e 910500PB137146086  |k 0/910000/  |k 1/910000/910500/  |p 1  |x j 
999 |a KXP-PPN1665915196  |e 3507137739 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"pubHistory":["1.1985 -"],"part":{"volume":"31","year":"2018","issue":"8","extent":"8","pages":"895-902","text":"31(2018), 8, Seite 895-902"},"language":["eng"],"titleAlt":[{"title":"JPEM"}],"disp":"Sequential measurements of IGF-I serum concentrations in adolescents with Laron syndrome treated with recombinant human IGF-I (rhIGF-I)The journal of pediatric endocrinology and metabolism","type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"641391293","origin":[{"dateIssuedKey":"1985","publisherPlace":"Berlin [u.a.] ; London","publisher":"de Gruyter ; Freund","dateIssuedDisp":"1985-"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"doi":["10.1515/jpem"],"zdb":["2583847-7"],"issn":["2191-0251"],"eki":["641391293"]},"title":[{"title_sort":"journal of pediatric endocrinology and metabolism","title":"The journal of pediatric endocrinology and metabolism","subtitle":"JPEM"}]}],"origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"11.07.2018"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title":"Sequential measurements of IGF-I serum concentrations in adolescents with Laron syndrome treated with recombinant human IGF-I (rhIGF-I)","title_sort":"Sequential measurements of IGF-I serum concentrations in adolescents with Laron syndrome treated with recombinant human IGF-I (rhIGF-I)"}],"id":{"eki":["1665915196"],"doi":["10.1515/jpem-2018-0139"]},"physDesc":[{"extent":"8 S."}],"recId":"1665915196","person":[{"given":"Thomas","display":"Breil, Thomas","family":"Breil","role":"aut"},{"given":"Carolin","display":"Kneppo, Carolin","role":"aut","family":"Kneppo"},{"role":"aut","family":"Bettendorf","given":"Markus","display":"Bettendorf, Markus"},{"family":"Müller","role":"aut","display":"Müller, Hermann L.","given":"Hermann L."},{"family":"Kapelari","role":"aut","display":"Kapelari, Klaus","given":"Klaus"},{"given":"Dirk","display":"Schnabel, Dirk","role":"aut","family":"Schnabel"},{"family":"Woelfle","role":"aut","display":"Woelfle, Joachim","given":"Joachim"}],"note":["Gesehen am 15.08.2019"],"language":["eng"],"name":{"displayForm":["Thomas Breil, Carolin Kneppo, Markus Bettendorf, Hermann L. Müller, Klaus Kapelari, Dirk Schnabel, Joachim Woelfle"]}} 
SRT |a BREILTHOMASEQUENTIAL1107